Teopeks

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Teopeks

Property Description
Active ingredient Choline Theophyllinate (INN)
Form Oral dosage forms (tablet, capsule, syrup, elixir)
Pharmacological class Bronchodilator; Methylxanthine Derivative
Common use Supporting maintenance of open airways
Origin Synthetic salt derivative

Teopeks: Identity and Pharmacological Classification

Teopeks is a medicinal entity identified by its single active component, Choline Theophyllinate, which is its internationally recognized non-proprietary name (INN). This systemic drug is classified as a bronchodilator and belongs to the therapeutic group of Xanthines. This pharmacological classification is clinically recognized for addressing the mechanical difficulty of air movement in the lungs.

Choline Theophyllinate is differentiated from pure Theophylline because it is a salt form designed to deliver the core compound with potentially enhanced solubility. The compound efficiently releases Theophylline in vivo, enabling the necessary therapeutic action for respiratory support.

Composition, Origin, and Available Forms

As a synthetic derivative, Choline Theophyllinate is reliably manufactured as a standardized salt rather than being isolated as an unmodified natural entity. This process ensures the pharmaceutical quality and consistency required for medications.

As a single active ingredient formulation, the medicine is prepared in various high-level oral dosage forms, including tablets, capsules, or syrup, all intended for oral administration. The salt structure is a key feature, utilizing Choline to improve the compound's characteristics, while standard excipients form the base for proper drug delivery.

What is the General Purpose of Choline Theophyllinate?

The general purpose of the compound is directly tied to its classification as a bronchodilator: to support respiratory function by promoting the relaxation of bronchial smooth muscle. This action is fundamental to easing the chronic constriction of airways.

By facilitating this sustained relaxation, the compound helps to widen the air passages. This action is intended to reduce the difficulty of air movement and ease the common sensation of chest tightness. The core purpose is to help maintain open airways, supporting the body’s overall air exchange capabilities in a reliable manner.

Regulatory References

  1. NIH

What side effects are possible with Teopeks?

Possible Side Effects and Safety Information

The safety profile of Teopeks (Theophylline) is closely linked to the concentration of the medicine in the blood, which is why Therapeutic Drug Monitoring (TDM) is required to guide dosage and minimize risks. Adverse effects generally increase in both frequency and severity when serum levels exceed the recommended therapeutic range.

Adverse Reactions by System and Frequency

Adverse reactions are classified according to the part of the body affected (System-Organ-Class) and how often they occur (Frequency Classification):

System-Organ Class Frequency Classification Examples of Reactions
Cardiac Disorders Very Common to Not Known Tachycardia, palpitations, cardiac arrhythmias
Nervous System Disorders Very Common to Not Known Headache, tremors, restlessness, seizures
Gastrointestinal Disorders Not Known Nausea, vomiting, diarrhea, persistent vomiting
Metabolism Disorders Very Common Hyperglycemia, hypokalemia

Serious Adverse Reactions

The regulatory label documents that seizures (convulsions) and life-threatening cardiac arrhythmias (e.g., ventricular tachycardias) are the most clinically serious adverse reactions. These severe effects are most likely to occur at toxic blood levels and may be fatal or cause permanent damage.

Safety-Related Restrictions and Considerations

  • Population Sensitivity: Specific caution and dose adjustments are required for older adults and patients with hepatic (liver) impairment or certain concurrent medical conditions (e.g., severe heart disease), as these factors can decrease the drug's clearance from the body, increasing the risk of toxicity.
  • Contraindications: Teopeks is typically contraindicated in individuals with known hypersensitivity to xanthine derivatives, recent myocardial infarction, or acute tachycardiac arrhythmia.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information for Teopeks (Choline Theophyllinate) overdose defines severe risks, primarily involving the Central Nervous System and Cardiovascular System. Due to the potential for rapid progression, immediate medical attention is required for any suspected overdose.

Documented Overdose Manifestations

System Documented Manifestations
Cardiovascular Fast and Irregular Heartbeat, Sinus and Ventricular Tachycardia, Hypotension
Neurological Agitation, Tremors, Restlessness, Confusion, Hallucinations, Seizures (Convulsions)
Gastrointestinal Nausea, Vomiting, Abdominal Pain, Diarrhea, Dark or Bloody Vomit

Severe Outcomes and Emergency Action

Life-threatening outcomes officially documented include Ventricular Arrhythmias, Cardiac Arrest, Seizures, and severe metabolic derangements like Hypokalemia and Hyperglycemia. Such symptoms necessitate immediate medical intervention and hospitalization for continuous monitoring.

Regulators require individuals to Call a POISON CENTER or doctor/physician immediately in the event of suspected overdose.

Overdose Management

No specific antidote is officially documented. Management is primarily supportive, focusing on stabilizing vital signs and reducing the drug load. This includes Continuous Monitoring and measurement of Serum Theophylline Levels. Elimination procedures like Hemodialysis are indicated for severe, life-threatening toxicity.

Population-Specific Risk

Increased risk of toxicity is documented in patients over 55 years of age and those with Impaired Liver Function or Cardiac Failure.

Therapeutic Uses of Teopeks

What Teopeks Treats: Main Uses and Benefits

Teopeks (Choline Theophyllinate) is commonly used across conditions involving episodic or fluctuating manifestations of chronic airway narrowing. This medication is primarily relevant for easing symptoms linked to airway narrowing in long-term conditions, notably bronchial asthma and Chronic Obstructive Pulmonary Disease (COPD). The compound is applied across therapeutic domains where additional symptomatic support is needed.

The therapeutic use contributes to easing the overall symptom load for conditions involving inflammatory or irritative processes. It helps manage symptom clusters that may become intense or disruptive, including wheezing, the physical discomfort of chest tightness, and pronounced shortness of breath that interferes with daily functioning.

“It supports patients during episodes of heightened discomfort and may assist with maintaining functional stability.”

This supportive treatment is relevant when symptoms become temporarily overwhelming, and is commonly used as part of a continuous, maintenance treatment plan. In therapeutic areas involving heightened responses, this medicine contributes to improved comfort during periods of heightened symptoms.


Quick Fact: Supports Easing Symptoms Related to Shortness of Breath and Chest Tightness

Eligibility and Restrictions for Use

Teopeks (Choline Theophyllinate) is subject to specific usage rules based on patient demographics and coexisting health conditions, as mandated by regulatory authorities.

Contraindications and Absolute Exclusions

This medicine must not be used by patients who have an absolute prohibition from regulatory bodies. This includes individuals with:

  • A known hypersensitivity to theophylline, other xanthine derivatives, or any component of the formulation.
  • Active Peptic Ulcer Disease.
  • An underlying Seizure Disorder (unless the condition is adequately controlled).

Age and Physiological Restrictions

Population Group Official Regulatory Status
Infants (<1 year) Use requires caution due to a higher risk of side effects from slower drug clearance.
Children (<10 years) Use is not established or not recommended in some regulatory labels.
Older Adults (>60 years) Use requires caution and monitoring due to an expected decrease in drug clearance.
Pregnancy (Third Trimester) Clearance is significantly decreased; categorized as FDA Category C.
Breastfeeding The drug is excreted in human milk; the manufacturer advises a decision to discontinue nursing or discontinue the drug.

Conditional Use Restrictions

Teopeks must be administered cautiously with close monitoring in patients experiencing conditions that impair drug clearance or increase sensitivity. These include Liver Disease (e.g., cirrhosis), Heart Failure, Sustained High Fever, and conditions causing Uncorrected Acidemia.

What should I know about interactions with other medicines?

The interaction profile of Teopeks, which releases Theophylline, is primarily defined by the susceptibility of its metabolic clearance to specific substances. Co-administration with certain medicinal products significantly alters the resulting plasma exposure.

Exposure-Altering Medicines

Medicines documented as metabolic inhibitors, such as Cimetidine, Ciprofloxacin, and Fluvoxamine, reduce the clearance of Theophylline. This action leads to an officially documented increase in plasma concentrations. Conversely, enzyme-inducing medicines, including Rifampin, Phenytoin, and Carbamazepine, increase the rate of clearance, resulting in documented lower plasma concentrations. Theophylline also exhibits specific pharmacodynamic effects, such as antagonizing the sedative effects of benzodiazepines and the potential cardiac sensitization associated with Halothane.

Substance and Administration Constraints

Specific substance consumption also modifies exposure. Both cigarette smoking and charcoal-broiled beef consumption are documented to increase clearance, while a single large dose of alcohol may decrease clearance. The clearance rate is officially reduced in certain populations, notably the elderly and those with hepatic impairment, which increases the risk of higher unbound drug concentrations. Furthermore, administration timing must be separated from enteral (tube) feedings by one hour before and one hour after the dose to mitigate documented absorption interference.

Mechanism of Action

How Teopeks Works

The active ingredient of Teopeks works through multiple, concurrent mechanisms, primarily by acting as a competitive inhibitor of Phosphodiesterase (PDE) enzymes, specifically PDE3 and PDE4. This inhibition prevents the hydrolysis of the second messenger cyclic AMP (cAMP), causing its concentration to rise within airway smooth muscle cells. This molecular cascade leads directly to the relaxation of bronchial smooth muscle, thereby producing a physiological widening of the air passages.

Simultaneously, the molecule operates as a nonselective antagonist of Adenosine receptors across various tissues. By blocking these receptors, the compound reduces the influence of Adenosine, which otherwise causes contraction of bronchial smooth muscle and the release of inflammatory mediators like histamine. A distinct, concentration-dependent action involves the indirect activation of Histone Deacetylase 2 (HDAC2) via inhibition of PI3K- delta. Functional HDAC2 restores the cell's natural ability to suppress the transcription of pro-inflammatory genes, resulting in a modulation of the underlying systemic inflammatory activity.

Dosage and Administration Information

The administration of Teopeks (Choline Theophyllinate) is guided by the prescribing information for its active component, Theophylline, a drug with a narrow therapeutic range. The primary goal of use is to maintain a stable drug concentration, which requires procedural precision and ongoing monitoring.

Route and Dosage Principles

The medicine is available for oral administration as tablets, capsules, or solutions, which is the standard route for long-term use. In controlled clinical settings, it may also be administered intravenously (IV). Dosing is highly individualized and aims to achieve a total serum theophylline concentration between 10 and 15 mcg/mL. This principle necessitates Therapeutic Drug Monitoring (TDM), where serum concentrations must be measured frequently during initiation and periodically thereafter. Dose adjustments, if needed, are made in small increments (typically 10% to 25%) at intervals of no less than three days.

Administration and Special Populations

For extended-release oral forms, the medicine is typically dosed every 12 hours. It is a mandatory administration constraint that extended-release tablets must be swallowed whole and must not be crushed, cut, or chewed to ensure the proper drug release rate. The medicine is intended solely for long-term maintenance and not for acute situations. Specific administration rules require lower total daily doses for older adults (over 60 years) and those with hepatic impairment due to reduced drug clearance. If a dose is missed, standard protocols specify taking it within a short time window, otherwise the scheduled regimen should be resumed without doubling the dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Teopeks


Evidence for use in Bronchial Asthma

Research was studied in individuals with bronchial asthma, a condition characterized by fluctuating or episodic manifestations of airway inflammation and obstruction. The clinical trials examined the patterns observed when Teopeks was used as an add-on treatment for patients whose asthma symptoms were not fully controlled by standard inhaled therapies.

Studies explored several outcomes related to systemic or functional imbalance. Findings from this research describe patterns associated with the frequency of acute severe episodes (exacerbations) in the observed populations. The research also monitored changes related to lung function measures and the frequency of oral corticosteroid use in certain observed populations.

Evidence for use in Chronic Obstructive Pulmonary Diseases (COPD)

Teopeks was evaluated in studies focused on Chronic Obstructive Pulmonary Diseases (COPD), which includes Chronic Obstructive Bronchitis and Pulmonary Emphysema. The research examined whether Teopeks was associated with patterns in outcomes reflecting daily functioning or activity level and the frequency of exacerbations in people with COPD. Findings were mixed across the available evidence, and the pattern of findings appears to differ based on the specific type or phenotype of COPD being observed in the studies.


Evidence in Special Populations

Research has explored its use in children (adolescents 12 years and older) with severe asthma. The findings in these pediatric populations generally describe patterns related to outcomes that were observed in adult studies, though the overall experience in this group is less extensive. For older adults and patients with multiple comorbid conditions, dedicated research is limited, and subgroup findings are uncertain.

What is Still Uncertain about Teopeks

Despite significant research, key uncertainties remain. Comparative evidence is lacking in certain areas, meaning more head-to-head research is needed to determine how the observed outcomes with Teopeks relate to other available treatments over time. Furthermore, while initial long-term data suggest patterns of continued observation, long-term effects are not fully established, particularly for patients followed for many years outside of the original clinical trial settings.

Key Studies & References

  1. Chronic Use of Theophylline and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-analysis (Long-term/risk context)

Frequently Asked Questions (FAQ)

Common questions about Teopeks (FAQ)

Q: Is it common to feel tired when starting Teopeks?

A: Official drug labels list central nervous system effects such as restlessness and tremors as common side effects. However, tiredness or fatigue are not typically cited among the most frequent side effects in official product information for this medicine.


Q: How long does Teopeks typically stay in your system?

A: The active ingredient's average half-life (the time it takes for half of the drug to be cleared) can vary widely, often ranging from 5 to 10 hours in healthy, non-smoking adults. This variability is why monitoring drug levels in the blood is necessary, which is done through Therapeutic Drug Monitoring (TDM).


Q: Does Teopeks interact with common pain relievers like ibuprofen?

A: Regulatory documents include a comprehensive table of known drug interactions that can significantly alter the medicine’s level in the blood. Ibuprofen, a common pain reliever, is not typically cited in official drug interaction warnings as significantly changing how the active ingredient is cleared from the body.


Q: Can older adults generally use Teopeks?

A: Yes, older adults (over 60 years) can generally use this medicine. However, official information indicates the need for careful monitoring and often a dose reduction due to expected lower drug clearance.


Q: How does the effectiveness of Teopeks change over a long period of time?

A: Official information does not discuss whether patients experience tolerance (a reduced response) to the medicine over time. However, to ensure the medicine continues to work as intended, regulatory documents recommend periodic serum concentration monitoring every 6 to 12 months in patients receiving long-term treatment.


Q: Does Teopeks interact with oral contraceptives?

A: Regulatory documents list Oral Contraceptives as a medication that can affect how the active ingredient is processed by the body. Taking these together can potentially lead to an officially documented increase in the medicine’s plasma concentrations, which may require monitoring.


Q: Is Teopeks the same type of medication as [Similar Drug Name]?

A: The active ingredient, Choline Theophyllinate, is a salt derivative of Theophylline. It is officially classified as a Methylxanthine Bronchodilator. This places it in the same pharmacological class as other xanthine-derived products, but it is a distinct chemical entity with its own specific formulation and properties.


Q: How quickly can I expect to notice the effects of Teopeks?

A: This medication is intended solely for long-term maintenance and is not approved for fast relief of acute breathing problems. When using extended-release forms, the maximum concentration in the blood is typically reached 4 to 8 hours after taking a dose, but the time to noticeable clinical effect varies for each individual.


Q: Can Teopeks be used for conditions other than what it is officially approved for?

A: According to regulatory documents, this medicine is indicated only for the treatment of symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases, such as emphysema and chronic bronchitis.


Q: What is the risk of dependence or addiction reported with Teopeks?

A: The active ingredient in Teopeks is not classified as a controlled substance by the US DEA or similar regulatory bodies internationally. The medicine is not typically associated with the addiction and misuse warnings found on labels for other classes of medication, such as opioids or benzodiazepines.


Q: What happens if I miss a dose of Teopeks?

A: Official instructions specify taking the dose within a short time window of the scheduled time. If the time window is missed, official instructions specify that the scheduled regimen should be resumed without doubling the dose.


Q: Is there a generic version of Teopeks available?

A: The active compound, Theophylline, is available in various FDA-approved generic formulations (often referenced as Abbreviated New Drug Applications) marketed under different generic and brand names globally.


Q: Why is Teopeks often discussed alongside diet changes?

A: Regulatory documents indicate that the clearance of the active ingredient can be significantly affected by dietary habits. For instance, the daily consumption of charcoal-broiled beef is documented to increase the rate at which the drug is cleared, while a high-carbohydrate/low-protein diet may decrease it.


Q: Is Teopeks safe to take with alcohol, based on public reports?

A: Regulatory documents state that a single large dose of alcohol may officially decrease the rate at which the active ingredient is cleared from the body. This reduction can potentially lead to increased drug concentrations and a greater risk of adverse effects.


Q: Can Teopeks affect my ability to drive or operate machinery?

A: While the official label does not include a specific driving warning, it lists central nervous system effects like seizures, tremors, and restlessness. These effects are listed as adverse reactions that may affect the ability to operate machinery.


Q: What is the typical timeframe for treatment with Teopeks?

A: The medicine is specifically indicated for long-term maintenance therapy for chronic respiratory conditions.


Q: Why do some people stop taking Teopeks?

A: Clinical literature notes that patients may discontinue treatment for two main reasons. The first is the experience of adverse effects, especially those that increase in frequency and severity when blood levels exceed the therapeutic range. The second common reason is a lack of sufficient symptomatic improvement after an adequate trial period.


Q: Does taking Teopeks require special monitoring or blood tests?

A: Yes, because the active ingredient has a narrow therapeutic range (meaning the effective dose is close to the toxic dose), Therapeutic Drug Monitoring (TDM) is required. This involves blood tests to measure the exact drug level, especially when starting therapy, changing doses, or adding other interacting medications.


Q: Is it common for Teopeks to be combined with other medications?

A: Clinical trials and regulatory documents describe the medicine's use as an add-on treatment for patients whose chronic respiratory symptoms were not fully controlled by standard inhaled therapies, such as inhaled steroids or beta-agonists.


Q: What time of day is Teopeks typically recommended for taking?

A: Official instructions specify that the medicine is administered at the same time each day to help maintain stable drug levels in the blood. Extended-release formulations are commonly dosed every 12 hours, with doses usually taken in the morning and evening, or as a single daily dose, depending on the specific product.


Q: Are there any reported instances of Teopeks losing its effectiveness over time?

A: Official information does not specifically report tolerance (a reduced response to the drug) in the clinical studies. However, official guidance recommends TDM to ensure that blood concentrations remain at therapeutic levels, which accounts for potential changes in the drug's clearance over time.


Q: How is Teopeks usually packaged or supplied?

A: The medicine is typically supplied in bottles of 100 tablets or capsules. The packaging and labeling will clearly list the specific drug name, its strength (e.g., 300 mg), and the route of administration (oral), consistent with regulatory packaging requirements.


Q: Can Teopeks affect sleep patterns or cause insomnia?

A: While the specific term insomnia (inability to sleep) may not be listed directly, regulatory documents classify restlessness as a common side effect affecting the nervous system. Restlessness is a central nervous system stimulation that could potentially impact sleep patterns.

How should Teopeks be stored and disposed of?

How to Store and Dispose of Teopeks?

The storage and disposal of Teopeks (Choline Theophyllinate) must align with official regulatory requirements to maintain product stability and ensure public safety.

Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep the container tightly closed and protect the product from moisture.
Safety The medicine must be kept out of the sight and reach of children and pets.

Disposal Instructions

Unused or expired medication should be disposed of promptly. The preferred method is to use a drug take-back program. If a program is unavailable, mix the medicine with an undesirable substance (such as dirt) in a sealed bag before placing it in the household trash. The medicine must not be flushed down the toilet or poured down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Teopeks found in:

A-Z Index: